Luisa Milazzo
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Multi-omics analyses identify EZH2 as a central driver in rhabdomyosarcoma radioresistance and highlight Tazemetostat as an effective radiosensitizer in vitro and in vivo.
Journal: Cell death & disease
Published: July 11, 2025
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks.
Journal: Cell death discovery
Published: February 07, 2024
Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma.
Journal: BMC cancer
Published: January 22, 2024
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo.
Journal: Frontiers in pharmacology
Published: October 15, 2022
Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma.
Journal: International journal of molecular sciences
Published: October 07, 2022
Radioresistance in rhabdomyosarcomas: Much more than a question of dose.
Journal: Frontiers in oncology
Published: August 11, 2022
Multimodal evaluation of 19F-BPA internalization in pancreatic cancer cells for boron capture and proton therapy potential applications.
Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
Published: August 16, 2021
MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells.
Journal: International journal of molecular sciences
Published: June 28, 2021
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype.
Journal: International journal of radiation biology
Published: May 12, 2021
Clinically relevant radioresistant rhabdomyosarcoma cell lines: functional, molecular and immune-related characterization.
Journal: Journal of biomedical science
Published: June 16, 2020
Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation.
Journal: International journal of radiation biology
Published: March 10, 2020
Wharton's jelly mesenchymal stromal cells have contrasting effects on proliferation and phenotype of cancer stem cells from different subtypes of lung cancer.
Journal: Experimental cell research
Published: November 27, 2015
Last Updated: 09/26/2026